vs
Side-by-side financial comparison of PagerDuty, Inc. (PD) and Syndax Pharmaceuticals Inc (SNDX). Click either name above to swap in a different company.
PagerDuty, Inc. is the larger business by last-quarter revenue ($124.5M vs $68.5M, roughly 1.8× Syndax Pharmaceuticals Inc). PagerDuty, Inc. runs the higher net margin — 129.7% vs -99.3%, a 229.1% gap on every dollar of revenue. On growth, Syndax Pharmaceuticals Inc posted the faster year-over-year revenue change (791.7% vs 4.7%).
PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.
Syndax Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative oncology therapies for patients with hard-to-treat cancers. Its pipeline includes targeted and immunotherapy candidates addressing unmet medical needs, primarily serving global oncology healthcare stakeholders and patient populations.
PD vs SNDX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $124.5M | $68.5M |
| Net Profit | $161.6M | $-68.0M |
| Gross Margin | 85.3% | — |
| Operating Margin | 6.5% | -91.3% |
| Net Margin | 129.7% | -99.3% |
| Revenue YoY | 4.7% | 791.7% |
| Net Profit YoY | 2827.7% | 27.8% |
| EPS (diluted) | $1.69 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $124.5M | $68.5M | ||
| Q3 25 | $123.4M | $45.9M | ||
| Q2 25 | $119.8M | $38.0M | ||
| Q1 25 | $121.4M | $20.0M | ||
| Q4 24 | $118.9M | — | ||
| Q3 24 | $115.9M | $12.5M | ||
| Q2 24 | $111.2M | — | ||
| Q1 24 | $111.1M | $0 |
| Q4 25 | $161.6M | $-68.0M | ||
| Q3 25 | $9.6M | $-60.7M | ||
| Q2 25 | $-7.2M | $-71.8M | ||
| Q1 25 | $-8.8M | $-84.8M | ||
| Q4 24 | $-5.9M | — | ||
| Q3 24 | $-10.9M | $-84.1M | ||
| Q2 24 | $-17.1M | — | ||
| Q1 24 | $-28.2M | $-72.4M |
| Q4 25 | 85.3% | — | ||
| Q3 25 | 84.6% | — | ||
| Q2 25 | 84.0% | — | ||
| Q1 25 | 83.6% | — | ||
| Q4 24 | 83.0% | — | ||
| Q3 24 | 82.7% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.7% | — |
| Q4 25 | 6.5% | -91.3% | ||
| Q3 25 | 2.9% | -125.2% | ||
| Q2 25 | -8.6% | -182.7% | ||
| Q1 25 | -9.6% | -417.9% | ||
| Q4 24 | -8.7% | — | ||
| Q3 24 | -13.8% | -716.6% | ||
| Q2 24 | -19.5% | — | ||
| Q1 24 | -30.1% | — |
| Q4 25 | 129.7% | -99.3% | ||
| Q3 25 | 7.8% | -132.4% | ||
| Q2 25 | -6.0% | -189.3% | ||
| Q1 25 | -7.2% | -423.3% | ||
| Q4 24 | -5.0% | — | ||
| Q3 24 | -9.4% | -673.0% | ||
| Q2 24 | -15.4% | — | ||
| Q1 24 | -25.3% | — |
| Q4 25 | $1.69 | $-0.78 | ||
| Q3 25 | $0.10 | $-0.70 | ||
| Q2 25 | $-0.07 | $-0.83 | ||
| Q1 25 | $-0.12 | $-0.98 | ||
| Q4 24 | $-0.07 | — | ||
| Q3 24 | $-0.14 | $-0.98 | ||
| Q2 24 | $-0.26 | — | ||
| Q1 24 | $-0.34 | $-0.85 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $547.8M | $394.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $320.5M | $64.6M |
| Total Assets | $1.0B | $529.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $547.8M | $394.1M | ||
| Q3 25 | $567.9M | $436.0M | ||
| Q2 25 | $597.1M | $455.2M | ||
| Q1 25 | $570.8M | $512.2M | ||
| Q4 24 | $542.2M | — | ||
| Q3 24 | $599.3M | $389.6M | ||
| Q2 24 | $592.8M | — | ||
| Q1 24 | $571.2M | $434.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $484.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $489.5M | — |
| Q4 25 | $320.5M | $64.6M | ||
| Q3 25 | $180.7M | $115.4M | ||
| Q2 25 | $145.7M | $157.4M | ||
| Q1 25 | $129.8M | $215.1M | ||
| Q4 24 | $111.6M | — | ||
| Q3 24 | $164.7M | $366.4M | ||
| Q2 24 | $174.0M | — | ||
| Q1 24 | $171.6M | $491.9M |
| Q4 25 | $1.0B | $529.7M | ||
| Q3 25 | $891.5M | $551.8M | ||
| Q2 25 | $926.8M | $596.1M | ||
| Q1 25 | $927.3M | $640.7M | ||
| Q4 24 | $866.8M | — | ||
| Q3 24 | $916.0M | $425.8M | ||
| Q2 24 | $924.0M | — | ||
| Q1 24 | $925.3M | $543.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.73× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.85× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $24.8M | $-69.5M |
| Free Cash FlowOCF − Capex | $24.1M | — |
| FCF MarginFCF / Revenue | 19.3% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | 0.15× | — |
| TTM Free Cash FlowTrailing 4 quarters | $117.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.8M | $-69.5M | ||
| Q3 25 | $34.0M | $-70.5M | ||
| Q2 25 | $30.7M | $-87.8M | ||
| Q1 25 | $31.4M | $-95.2M | ||
| Q4 24 | $22.1M | — | ||
| Q3 24 | $35.8M | $-62.3M | ||
| Q2 24 | $28.6M | — | ||
| Q1 24 | $22.2M | $-83.5M |
| Q4 25 | $24.1M | — | ||
| Q3 25 | $33.1M | — | ||
| Q2 25 | $30.2M | — | ||
| Q1 25 | $30.3M | — | ||
| Q4 24 | $21.5M | — | ||
| Q3 24 | $35.1M | — | ||
| Q2 24 | $28.2M | — | ||
| Q1 24 | $21.2M | — |
| Q4 25 | 19.3% | — | ||
| Q3 25 | 26.8% | — | ||
| Q2 25 | 25.2% | — | ||
| Q1 25 | 24.9% | — | ||
| Q4 24 | 18.1% | — | ||
| Q3 24 | 30.3% | — | ||
| Q2 24 | 25.4% | — | ||
| Q1 24 | 19.1% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | 0.15× | — | ||
| Q3 25 | 3.55× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
SNDX
Segment breakdown not available.
